Current Report Filing (8-k)
October 06 2022 - 8:01AM
Edgar (US Regulatory)
0001847846
false
0001847846
2022-08-30
2022-08-30
0001847846
LAXXU:UnitsConsistingOfOneOrdinaryShareNoParValueOneRedeemableWarrantToAcquireOnehalf12OfOneOrdinaryShareAndOneRightToAcquireOnetenthOfOrdinaryShareMember
2022-08-30
2022-08-30
0001847846
LAXXU:OrdinarySharesIncludedAsPartOfUnitsMember
2022-08-30
2022-08-30
0001847846
LAXXU:RedeemableWarrantsIncludedAsPartOfUnitsMember
2022-08-30
2022-08-30
0001847846
LAXXU:RightsIncludedAsPartOfUnitsMember
2022-08-30
2022-08-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 30, 2022
8i
Acquisition 2 Corp.
(Exact
Name of Registrant as Specified in its Charter)
British
Virgin Islands |
|
001-40462 |
|
n/a |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
c/o
6 Eu Tong Seng Street
#08-13
Singapore 059817
(Address
of Principal Executive Offices and Zip Code)
Registrant’s
telephone number, including area code: +65-6788 0388
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☒ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
|
|
|
|
|
Units consisting of one
Ordinary Share, no par value, one Redeemable Warrant to acquire one-half (1/2) of one Ordinary Share, and one Right to acquire one-tenth
of an Ordinary Share |
|
LAXXU |
|
NASDAQ Stock Market LLC |
|
|
|
|
|
Ordinary Shares included
as part of the Units |
|
LAX |
|
NASDAQ
Stock Market LLC |
|
|
|
|
|
Redeemable Warrants included
as part of the Units |
|
LAXXW |
|
NASDAQ Stock Market LLC |
|
|
|
|
|
Rights included as part
of the Units |
|
LAXXR |
|
NASDAQ Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
7.01. Regulation FD Disclosure
8i
Acquisition 2 Corp. (the “Company”) retained and compensated Fundamental Research Corp. to prepare a research report on the
Company and EUDA Health Limited. The research report attached hereto as Exhibit 99.1 is being furnished pursuant to Item 7.01 of this
Current Report and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that Section.
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
October 6, 2022
8i
Acquisition 2 Corp. |
|
|
|
|
By: |
/s/
Meng Dong (James) Tan |
|
Name: |
Meng
Dong (James) Tan |
|
Title: |
Chief
Executive Officer |
|
8i Acquisition 2 (NASDAQ:LAXXU)
Historical Stock Chart
From May 2024 to Jun 2024
8i Acquisition 2 (NASDAQ:LAXXU)
Historical Stock Chart
From Jun 2023 to Jun 2024